NEW YORK (GenomeWeb News) – Affymetrix said yesterday it will avoid having to pay certain convertible note holders earlier than expected once it files its delayed second-quarter earnings report with the Securities and Exchange Commission next month.
 
Affy yesterday said that on Aug. 17 it received a notice from certain investors saying it had defaulted on the terms of its $120 million convertible note program because it had delayed filing its financial statements with the SEC for the three months ended June 30.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.